Consumption of pomegranate decreases plasma lipopolysaccharide-binding protein levels, a marker of metabolic endotoxemia, in patients with newly diagnosed colorectal cancer: a randomized controlled clinical trial
about
Consumption of pomegranate decreases plasma lipopolysaccharide-binding protein levels, a marker of metabolic endotoxemia, in patients with newly diagnosed colorectal cancer: a randomized controlled clinical trial
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Consumption of pomegranate dec ...... ized controlled clinical trial
@en
Consumption of pomegranate dec ...... ized controlled clinical trial
@nl
type
label
Consumption of pomegranate dec ...... ized controlled clinical trial
@en
Consumption of pomegranate dec ...... ized controlled clinical trial
@nl
prefLabel
Consumption of pomegranate dec ...... ized controlled clinical trial
@en
Consumption of pomegranate dec ...... ized controlled clinical trial
@nl
P2093
P50
P356
P1433
P1476
Consumption of pomegranate dec ...... ized controlled clinical trial
@en
P2093
F J Rodríguez-Gil
Francisco Martínez-Díaz
M A Ávila-Gálvez
T Monedero-Saiz
P304
P356
10.1039/C8FO00264A
P577
2018-05-01T00:00:00Z